Seminars on Lesch-Nyhan syndrome. Discussion of unanswered questions.
D000493:Allopurinol / Q000627:therapeutic use; D002110:Caffeine / Q000378:metabolism; D002490:Central Nervous System / Q000378:metabolism*; D006527:Hepatolenticular Degeneration / Q000503:physiopathology; D006801:Humans; D006816:Huntington Disease / Q000473:pathology; D008607:Intellectual Disability; D010300:Parkinson Disease / Q000378:metabolism; D011339:Probenecid / Q000627:therapeutic use; D011686:Purine-Pyrimidine Metabolism, Inborn Errors; D011687:Purines / Q000378:metabolism*; D011743:Pyrimidines / Q000652:urine; D012313:RNA / Q000378:metabolism; D012730:Sex Chromosomes; D009626:Terminology as Topic; D014166:Transferases; D014527:Uric Acid / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*
D011687:Purines; D011743:Pyrimidines; D014527:Uric Acid; D002110:Caffeine; D012313:RNA; D000493:Allopurinol; D014166:Transferases; D011339:Probenecid